Dr. Daniel Latham, Novartis - Qepler Summits And Conferences

Dr. Daniel Latham

Head – Device Development & LCM
Novartis
Basel, Switzerland
Novartis

Daniel Latham is the Head of Device Development & LCM, where he leads an organisation of around 120 associates responsible for the development and life cycle management of delivery systems of drug/device combinations for both new biologic entities, biosimilars, and new chemical entities.

Over the past 11 years at Novartis, he has overseen significant device and primary packaging developments and launches and has significantly supported the growth of device development and drug/device interaction within the organisation.

Prior to Novartis, he worked in a variety of roles in consumer health¬care, focusing on the development of OTC medicines, transdermal patches, and medical devices.

He has a Ph.D. in controlled drug delivery from Queen Mary, Uni¬versity of London and a bachelor’s degree and master’s degrees in engineering from the University of Sheffield.

Related Sessions:

Drug/Device Combination
Products Summit 2018

Get up to date with the regulatory and quality compliance strategies for combination product development.
  • 04 Dec 2018
  • Berlin, DE
  • Pharma
Day 1: Tuesday, 04 December 2018
BLOCK: NAVIGATING THROUGH REGULATORY COMPLEXITY.
CASE STUDY: Using the delivery system concept to streamline drug/device combination approval in EU in accordance with MDR and article 117 requirements.
  • Delivery system concept in pharma and managing future complexity
  • Delivery system platforms and set up
  • Strategies for streamlining approval of drug/device combinations in EU with respect to introduction of MDR and article 117
View Details

Pre-Filled Syringes
Summit 2018

Enhance a fully integrated system approach for developing pre-filled syringes to maintain patient centricity.
  • 31 May 2018
  • Berlin, DE
  • Pharma
Day 1: Thursday, 31 May 2018
BLOCK: DEVICES MEET NEXT GENERATION FORMULATIONS.
CASE STUDY: Developing delivery systems comprising pre-filled syringes and injection devices.
  • Combination products and delivery systems – reducing development risk.
  • Importance of understanding the design space of a delivery system.
  • Considerations for setting up platforms for delivery systems.
View Details

2nd Annual Pre-Filled
Syringes Summit 2019

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 04 Jun 2019
  • Barcelona, ES
  • Pharma
Day 1: Tuesday, 04 June 2019
BLOCK: DEVICES MEET NEXT GENERATION FORMULATIONS.
CASE STUDY: Enabling innovation and managing complexity in Pharma
  • Innovation - what’s next for Pharma?
  • Organising around delivery systems
  • Primary packaging considerations
View Details

3rd Annual Pre-Filled
Syringes Summit 2020

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 28 May 2020
  • Prague, CZ
  • Pharma
Day 1: Thursday, 28 May 2020
CASE STUDY: To Be Announced
View Details

Medical Device
Regulations Summit 2021

Exploring EU MDR and IVDR updates and preparing company for new requirements implementation.
  • 08 Jul 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 08 July 2021
CASE STUDY: To Be Announced
View Details

3rd Annual Pre-Filled
Syringes Summit 2021

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 27 May 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 27 May 2021
CASE STUDY: To Be Announced
View Details